Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$3.16B |
| 2 |
Merck
MRK
|
+$2.72B |
| 3 |
SLB Ltd
SLB
|
+$1.62B |
| 4 |
Target
TGT
|
+$1.6B |
| 5 |
General Mills
GIS
|
+$930M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.81B |
| 2 |
Blackrock
BLK
|
+$2.57B |
| 3 |
US Bancorp
USB
|
+$1.84B |
| 4 |
M&T Bank
MTB
|
+$808M |
| 5 |
Huntington Bancshares
HBAN
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.45% |
| 2 | Financials | 11.9% |
| 3 | Healthcare | 10.6% |
| 4 | Consumer Discretionary | 9.01% |
| 5 | Industrials | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
iShares Core S&P US Growth ETF
IUSG
$33.6B
| $7.72M | ﹤0.01% |
60,723
-4,891
| -7% | -$676K |
|
2077
Green Plains
GPRE
$1.05B
| $7.72M | ﹤0.01% |
1,590,954
+189,478
| +14% | +$1.36M |
|
2078
British American Tobacco
BTI
$129B
| $7.7M | ﹤0.01% |
186,084
+26,721
| +17% | +$1.05M |
|
|
ADAM
2079
Adamas Trust
ADAM
$879M
| $7.65M | ﹤0.01% |
1,179,141
+105,288
| +10% | +$671K |
|
2080
Grab
GRAB
$15.1B
| $7.64M | ﹤0.01% |
1,686,789
+225,660
| +15% | +$1.05M |
|
2081
Nu Skin
NUS
$261M
| $7.64M | ﹤0.01% |
1,052,384
+336,807
| +47% | +$2.45M |
|
|
XRN
2082
Chiron Real Estate Inc
XRN
$477M
| $7.64M | ﹤0.01% |
174,593
-826
| -0.5% | -$34.1K |
|
2083
Cipher Digital
CIFR
$7.27B
| $7.63M | ﹤0.01% |
3,319,563
+180,010
| +6% | +$819K |
|
2084
Viridian Therapeutics
VRDN
$2.58B
| $7.63M | ﹤0.01% |
565,963
-9,107
| -2% | -$155K |
|
2085
Columbus McKinnon
CMCO
$599M
| $7.62M | ﹤0.01% |
449,938
+37,363
| +9% | +$971K |
|
2086
Thryv Holdings
THRY
$115M
| $7.62M | ﹤0.01% |
594,512
+13,824
| +2% | +$229K |
|
|
HOUS
2087
DELISTED
Anywhere Real Estate
HOUS
| $7.59M | ﹤0.01% |
2,280,470
+1,200,823
| +111% | +$4.25M |
|
2088
Bank First Corp
BFC
$1.7B
| $7.53M | ﹤0.01% |
74,706
-857
| -1% | -$86.8K |
|
2089
Winmark
WINA
$1.28B
| $7.51M | ﹤0.01% |
23,620
-626
| -3% | -$223K |
|
|
BRSP
2090
BrightSpire Capital
BRSP
$650M
| $7.5M | ﹤0.01% |
1,349,062
+107,265
| +9% | +$627K |
|
2091
Energy Recovery
ERII
$444M
| $7.49M | ﹤0.01% |
471,490
-3,983
| -0.8% | -$60.6K |
|
2092
Live Oak Bancshares
LOB
$1.96B
| $7.49M | ﹤0.01% |
280,875
-3,127
| -1% | -$104K |
|
2093
Merchants Bancorp
MBIN
$2.46B
| $7.49M | ﹤0.01% |
202,352
-4,930
| -2% | -$194K |
|
2094
Centrus Energy
LEU
$3.54B
| $7.47M | ﹤0.01% |
120,064
-1,328
| -1% | -$112K |
|
2095
Tompkins Financial
TMP
$1.41B
| $7.47M | ﹤0.01% |
118,539
-17,347
| -13% | -$1.16M |
|
2096
Core Laboratories
CLB
$517M
| $7.46M | ﹤0.01% |
497,990
-1,309
| -0.3% | -$21.9K |
|
2097
Methanex
MEOH
$4.12B
| $7.45M | ﹤0.01% |
212,388
-1,047
| -0.5% | -$47K |
|
2098
Constellium
CSTM
$3.96B
| $7.44M | ﹤0.01% |
736,878
-187,266
| -20% | -$1.99M |
|
2099
OR Royalties Inc
OR
$6.18B
| $7.43M | ﹤0.01% |
352,255
+4,212
| +1% | +$80.9K |
|
2100
STAAR Surgical
STAA
$1.17B
| $7.39M | ﹤0.01% |
419,350
-24,940
| -6% | -$500K |
|
Similar funds
Charles Schwab's Q1 2025 Portfolio in Review
As of Q1 2025, Charles Schwab held 3,548 positions worth $533B, down 1.7% from $542B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 3.6%. Charles Schwab opened 55 new positions and exited 74, leaving the 3,548-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2025 buy was iShares Currency Hedged MSCI Eurozone ETF: 7,259,426 shares worth $283M.
- Charles Schwab added most to ConocoPhillips in Q1 2025, an estimated $3.16B increase.
- Charles Schwab's biggest Q1 2025 reduction was Pfizer, cutting an estimated $2.81B.
- Charles Schwab fully exited Brookfield in Q1 2025, selling an estimated $218M.
- Charles Schwab's ten largest holdings make up 20% of its $533B portfolio in Q1 2025.
- Charles Schwab opened 55 new positions and closed 74 in Q1 2025.
- Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $533B.
Based on Charles Schwab's 13F filing for Q1 2025, filed 9 May 2025.